Detalhe da pesquisa
1.
Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors.
Clin Cancer Res;
23(19): 5923-5935, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28679766
2.
Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures.
Mol Cancer Ther;
15(7): 1614-26, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27196767
3.
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.
Clin Cancer Res;
22(13): 3260-7, 2016 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26888827